Goldberg Mark Alan - Insider Non-Derivative Transactions at Blueprint Medicines Corp (BPMC) - (SEC)
Updated on January 3, 2026.
According to recent SEC insider information filed on Jul 17, 2025, Goldberg Mark Alan's relationship to Blueprint Medicines Corp (BPMC) is Director, and currently has 18,254 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BPMC insiders.
Related Topics: SEC Topic List.
Data Source: SEC.
Goldberg Mark Alan - Insider Non-Derivative Transactions of BPMC Common Stock
Goldberg Mark Alan - Insider Non-Derivative Transactions at BPMC
Items per page:
25
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 18, 2025 | U -- (Common Stock) | 18254 | 0 | 0 |
| Jul 18, 2025 | Disposition -- (Common Stock) | 3902 | 0 | 18254 |
| Jun 19, 2025 | Acquisition -- (Common Stock) | 3902 | 128.12 | 22156 |
| Jun 13, 2024 | Acquisition -- (Common Stock) | 2242 | 0 | 18254 |
| Jun 22, 2023 | Acquisition -- (Common Stock) | 2600 | 0 | 16012 |